Emily Rollins - Dolby Laboratories Independent Director
| DLB Stock | USD 80.55 0.30 0.37% |
Insider
Emily Rollins is Independent Director of Dolby Laboratories since 2021.
| Age | 50 |
| Tenure | 3 years |
| Address | 1275 Market Street, San Francisco, CA, United States, 94103-1410 |
| Phone | 415 558 0200 |
| Web | https://www.dolby.com |
Dolby Laboratories Management Efficiency
The company has Return on Asset of 0.0516 % which means that on every $100 spent on assets, it made $0.0516 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0892 %, implying that it generated $0.0892 on every 100 dollars invested. Dolby Laboratories' management efficiency ratios could be used to measure how well Dolby Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. As of November 23, 2024, Return On Tangible Assets is expected to decline to 0.08. In addition to that, Return On Capital Employed is expected to decline to 0.09. At present, Dolby Laboratories' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 358.1 M, whereas Total Assets are forecasted to decline to about 2 B.Similar Executives
| Showing other executives | INSIDER Age | ||
| John Boyer | Maximus | 76 | |
| Robert Olsen | Network 1 Technologies | 61 | |
| CPA CPA | Network 1 Technologies | 72 | |
| Carol Jackson | AZZ Incorporated | 48 | |
| Scott Staples | First Advantage Corp | 59 | |
| Jeanne Scannell | Cass Information Systems | N/A | |
| Jonathan Esq | BrightView Holdings | 57 | |
| Louay Khatib | BrightView Holdings | N/A | |
| Venita Allen | AZZ Incorporated | 60 | |
| Ilene Baylinson | Maximus | 66 | |
| C Blankenship | Civeo Corp | 71 | |
| Allan Schoening | Civeo Corp | 65 | |
| Teresa Weipert | Maximus | 69 | |
| Steven Marks | First Advantage Corp | 37 | |
| Constance Moore | Civeo Corp | 65 | |
| A Sherman | CBIZ Inc | 55 | |
| Richard Marabito | CBIZ Inc | 57 | |
| Kenneth Lavelle | AZZ Incorporated | 63 | |
| Frank Lopez | BrightView Holdings | 46 | |
| Gary Booker | Rentokil Initial PLC | 53 | |
| Bruce Kowalski | CBIZ Inc | 59 | |
Management Performance
| Return On Equity | 0.0892 | ||||
| Return On Asset | 0.0516 |
Dolby Laboratories Leadership Team
Elected by the shareholders, the Dolby Laboratories' board of directors comprises two types of representatives: Dolby Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dolby. The board's role is to monitor Dolby Laboratories' management team and ensure that shareholders' interests are well served. Dolby Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dolby Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ioan Allen, Senior President | ||
| N Jasper, Independent Director | ||
| Maggie ODonnell, Head Relations | ||
| Giles Baker, Senior Vice President Consumer Entertainment | ||
| Ryan Nicholson, VP Controller | ||
| Linda Rogers, Senior Officer | ||
| Andy Sherman, General VP | ||
| Robert Park, Chief Financial Officer, Senior Vice President | ||
| Craig Todd, CTO VP | ||
| Avadis Tevanian, Independent Director | ||
| Simon Segars, Independent Director | ||
| Steven Forshay, Senior Vice President - Advanced Technology Group | ||
| David Dolby, Independent Director | ||
| Andy JD, General VP | ||
| Doug Darrow, Senior Group | ||
| Peter Gotcher, Independent Chairman of the Board | ||
| Peter Goldmacher, Vice Relations | ||
| John Couling, Senior Entertainment | ||
| Todd Pendleton, Senior Vice President Chief Marketing Officer | ||
| Roger Siboni, Independent Director | ||
| Lewis Chew, Chief Financial Officer, Executive Vice President | ||
| Mark Sherman, Executive Vice President General Counsel, Corporate Secretary | ||
| Anjali Sud, Independent Director | ||
| Micheline Chau, Independent Director | ||
| Kevin Yeaman, CEO and President Director and Member of Stock Plan Committee | ||
| Edwin Marin, Senior Officer | ||
| Tony Prophet, Independent Director | ||
| Emily Rollins, Independent Director |
Dolby Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dolby Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0892 | ||||
| Return On Asset | 0.0516 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 7.39 B | ||||
| Shares Outstanding | 59.77 M | ||||
| Shares Owned By Insiders | 1.47 % | ||||
| Shares Owned By Institutions | 93.97 % | ||||
| Number Of Shares Shorted | 887.73 K | ||||
| Price To Earning | 23.36 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Dolby Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dolby Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dolby Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dolby Laboratories Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dolby Laboratories. If investors know Dolby will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dolby Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.353 | Earnings Share 2.69 | Revenue Per Share 13.172 | Quarterly Revenue Growth (0.03) | Return On Assets 0.0516 |
The market value of Dolby Laboratories is measured differently than its book value, which is the value of Dolby that is recorded on the company's balance sheet. Investors also form their own opinion of Dolby Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Dolby Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dolby Laboratories' market value can be influenced by many factors that don't directly affect Dolby Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dolby Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dolby Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dolby Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.